Cel Sci Corporation (CVM)

[rwa3848]

Next Week? vs. Cash for Gold scream sushi & the other self-interested & longtime stock prognosticators on this board Many competitors reported failed trials during HN month. While it would have been sweetly poetic to have had CVM report Multikine as a cure for HN on the last day of the month, it was always unlikely. With that being said, if the Multikine drug trial had failed, there was no shame to be found in reporting in chorus with the competitors. As such, it seems multikine may very well have proven to be an effective treatment for HN (I can't wait to learn if its effectiveness derives from its cytokine ability to disrupt cancer's energy use for cell division & metastasis thus allowing cell suicide to finally complete in host cells thereby effectively wounding the cancer with breaches penetrable by various healthy immune cells & platelets)